Medimaging Integrated Solution Inc.

As of June 30, 2026, Medimaging Integrated Solution Inc. carries a market capitalization of 2.29B, placing it among publicly traded companies globally. Its enterprise value stands at 2.34B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Medimaging Integrated Solution Inc.'s next confirmed earnings release is scheduled for November 6, 2026.

As of June 30, 2026, Medimaging Integrated Solution Inc. has 40.23M shares outstanding.

As of June 30, 2026, Medimaging Integrated Solution Inc. trades at a trailing price-to-earnings ratio of 153.76. The price-to-sales ratio is 3.23, and the price-to-book ratio stands at 2.69.

As of June 30, 2026, Medimaging Integrated Solution Inc. trades at an EV/EBITDA multiple of 47.16 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 3.43 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 2.34B versus a market cap of 2.29B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Medimaging Integrated Solution Inc. maintains a current ratio of 2.54, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 78.37, indicating elevated leverage, while an interest coverage ratio of 3.47 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Medimaging Integrated Solution Inc. posted a return on equity (ROE) of 1.85, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) is negative at -0.38, so the business is destroying capital rather than earning a return above its cost of capital. Return on assets (ROA) stands at 0.97, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 1.82, useful for judging operating efficiency across full business cycles. The company generates approximately 4.21M in revenue per employee across its workforce of 162.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.68 indicates how many times Medimaging Integrated Solution Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Medimaging Integrated Solution Inc. recorded 6.08M in income tax expense. That works out to an effective tax rate of 29.79, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 20.40M, leaving 14.32M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Medimaging Integrated Solution Inc.'s stock has declined approximately 44.00% over the past 52 weeks. The 50-day moving average sits at 56.34, while the 200-day moving average is 68.12.

Over the twelve months ended June 30, 2026, Medimaging Integrated Solution Inc. generated 682.01M in revenue and converted that into 14.32M in net income, yielding earnings per share of 0.37. EBITDA reached 49.62M, while operating income came in at 10.46M.

As of June 30, 2026, Medimaging Integrated Solution Inc. holds 617.44M in cash and equivalents against 667.89M in total debt, resulting in a net debt position of 180.01M. Total book value stands at 852.27M, with working capital of 677.18M providing operational flexibility.

Medimaging Integrated Solution Inc. produced -40.53M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -37.12M in capital expenditures, free cash flow totaled -77.65M - equivalent to -2.01 per share.

Over the twelve months ended June 30, 2026, Medimaging Integrated Solution Inc. posted a gross margin of 39.19, reflecting its pricing power and cost economics. The operating margin of 1.53 and net profit margin of 2.10 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Medimaging Integrated Solution Inc. paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -3.53: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -13.99, meaning Medimaging Integrated Solution Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Medimaging Integrated Solution Inc.'s most recent stock split took place on December 29, 2025 with a 275:279 split ratio.

As of June 30, 2026, Medimaging Integrated Solution Inc. has an Altman Z-Score of 2.64, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.